UnitedHealth Group Incorporated $UNH Stock: Townsend & Associates Inc Decreases Position

Townsend & Associates Inc lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 76.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 819 shares of the healthcare conglomerate’s stock after selling 2,711 shares during the period. Townsend & Associates Inc’s holdings in UnitedHealth Group were worth $329,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Wellington Altus USA Inc. grew its stake in shares of UnitedHealth Group by 97.1% during the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 33 shares in the last quarter. Security National Bank of SO Dak purchased a new position in UnitedHealth Group in the second quarter valued at $29,000. Nvwm LLC raised its stake in UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 33 shares in the last quarter. Aberdeen Wealth Management LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $31,000. Finally, Compass Wealth Management LLC purchased a new stake in UnitedHealth Group during the 3rd quarter worth about $29,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Third-quarter beat and raised outlook support the shares. Adjusted EPS rose approximately 61% to $4.69, exceeding the $4.14 consensus estimate, while revenue reached $112.7 billion versus expectations of $111.3 billion. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in its cost controls and execution. UnitedHealth beat-and-raise quarter
• Positive Sentiment: Optum Health’s performance improved materially. The unit’s profit increased to $735 million, helping demonstrate operating leverage and contributing to UnitedHealth’s post-earnings recovery. Optum Health profit surge
• Positive Sentiment: Analyst expectations and valuation support remain favorable. Erste Group raised its FY2026 EPS estimate to $20.55 from $19.86 and its FY2027 estimate to $23.29 from $22.51. Mizuho also lifted its price target to $500 from $493 and maintained an “outperform” rating, implying additional upside from the referenced price. Mizuho raises UnitedHealth price target
• Neutral Sentiment: Investor attention and value-based coverage may increase trading interest. Zacks highlighted heightened investor attention and characterized UNH as a value stock, but these are sentiment and screening signals rather than new fundamental developments. Zacks value-stock analysis
• Negative Sentiment: Higher 2027 Medicare costs could pressure affordability and margins. The planned increase in costs for seniors may create political and utilization concerns, potentially offsetting some of the recent earnings momentum. Healthcare stocks also faced broader sector pressure in recent trading. UnitedHealth 2027 Medicare costs

Wall Street Analyst Weigh In

A number of research firms have recently commented on UNH. Truist Financial increased their price objective on UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Oppenheimer raised their target price on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. TD Cowen restated a “hold” rating and set a $402.00 target price on shares of UnitedHealth Group in a research note on Thursday, October 15th. Sanford C. Bernstein lowered their price target on UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a report on Wednesday, October 14th. Finally, Wall Street Zen upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $463.80.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

NYSE UNH opened at $417.97 on Monday. The company has a fifty day moving average of $388.47 and a two-hundred day moving average of $390.48. The company has a market capitalization of $375.16 billion, a PE ratio of 23.87, a P/E/G ratio of 1.51 and a beta of 0.60. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business had revenue of $112.70 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the firm earned $2.59 earnings per share. The business’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.